TD Waterhouse Canada’s Zomedica Corp. ZOM Stock Holding History

TD Waterhouse Canada’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-925	Closed	-$55	–	2124
2025 Q1	$55	Hold	925	–	–	﹤0.01%	1886
2024 Q4	$111	Hold	925	–	–	﹤0.01%	1879
2024 Q3	$120	Sell	925 -2,075	-69%	-$291	﹤0.01%	1812
2024 Q2	$438	Hold	3,000	–	–	﹤0.01%	1785
2024 Q1	$562	Hold	3,000	–	–	﹤0.01%	1765
2023 Q4	$734	Hold	3,000	–	–	﹤0.01%	1574
2023 Q3	$669	Hold	3,000	–	–	﹤0.01%	1577
2023 Q2	$815	Sell	3,000 -24,100	-89%	-$4.89K	﹤0.01%	1619
2023 Q1	$7.66K	Buy	27,100 +3,000	+12%	+$736	﹤0.01%	1277
2022 Q4	$5.24K	Hold	24,100	–	–	﹤0.01%	1339
2022 Q3	$6.87K	Hold	24,100	–	–	﹤0.01%	1292
2022 Q2	$6.47K	Hold	24,100	–	–	﹤0.01%	1334
2022 Q1	$9.97K	Buy	+24,100	New	+$7.89K	﹤0.01%	1333

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

TD Waterhouse Canada's ZOM Position: Q2 2025 in Review

TD Waterhouse Canada sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 925 shares — an estimated $55 sold.

TD Waterhouse Canada first reported a position in ZOM in Q1 2022 and held it in 13 quarters. The position peaked at $9.97K in Q1 2022. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

TD Waterhouse Canada reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
TD Waterhouse Canada sold 925 Zomedica Corp. shares in Q2 2025, an estimated $55.
TD Waterhouse Canada first reported a position in Zomedica Corp. in Q1 2022 and held it in 13 quarters.
TD Waterhouse Canada's Zomedica Corp. position peaked at $9.97K in Q1 2022.
10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on TD Waterhouse Canada's 13F filing for Q2 2025, filed 11 Aug 2025.